Amgen Announces Repatha™ Co-Preferred Position on Express Scripts National Formulary
October 06, 2015 at 17:17 PM EDT
Amgen (NASDAQ: AMGN) today announced that Express Scripts will provide access to Repatha™ (evolocumab) through its national ...
